Improved sensitivity using liquid chromatography mass spectrometry (LC-MS) for detection of propyl chloroformate derivatised β-N-methylamino-L-alanine (BMAA) in cyanobacteria

Water SA

Volumn 37, Issue 2, 2011, Pages 133-138

  Esterhuizen Londt, M ^a   Downing, S ^a   Downing, T G ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

N methylamino L alanine; BMAA; LC MS; LC MS MS

Indexed keywords

ANALYTICAL METHOD; BMAA; CHLOROFORMATES; CHROMATOGRAPHIC SEPARATIONS; COMPLEX MATRICES; DERIVATISATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; L-ALANINE; LC-MS; LC-MS METHODS; LC-MS/MS; LIQUID CHROMATOGRAPHIC SEPARATIONS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LOW CONCENTRATIONS; MULTIPLE INJECTIONS; MULTIPLE USER; SINGLE QUADRUPOLE MASS SPECTROMETRY; TRIPLE-QUADRUPOLE MASS SPECTROMETRY;

AMINO ACIDS; COLUMN CHROMATOGRAPHY; GAS CHROMATOGRAPHY; IONS; LIQUIDS; MASS SPECTROMETRY;

LIQUID CHROMATOGRAPHY;

AMINO ACID; CONCENTRATION (COMPOSITION); CYANOBACTERIUM; DETECTION METHOD; IDENTIFICATION METHOD; ION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR ANALYSIS; SENSITIVITY ANALYSIS;

CYANOBACTERIA;

EID: 79955076611     PISSN: 03784738     EISSN: 18167950     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BANACK SA and COX PA (2003) Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurol. 61 387-389.
2. BANACK SA, MURCH SJ and COX PA (2006) Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J. Ethnopharmacol. 106 (1) 97-104.
3. BANACK SA, JOHNSON HE, CHENG R and COX PA (2007) Production of the Neurotoxin BMAA by a marine cyanobacterium. Mar. Drugs 5 180-196.
4. COX PA and SACKS OW (2002) Cycad neurotoxin, consumption of flying foxes, and ALS/PDC disease in Guam. Neurol. 58 956-959.
5. COX PA, BANACK SA and MURCH SJ (2003) Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. PNAS 100 13380-13383.
6. COX PA, BANACK SA, MURCH SJ, RASMUSSEN U, TIEN G, BIDIGARE RR, METCALF J, MORRISON LF, CODD GA and BERGMAN B (2005) Diverse taxa of cyanobacteria produce-β-N-methylamino-L-alanine, a neurotoxic amino acid. PNAS 102 5074-5078.
7. DUNCAN MW, STEELE JC, KOPIN IJ and MARKEY SP (1990) 2-Amino-3-(methylamino)-propionic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurol. 40 767-772.
8. ESTERHUIZEN M and DOWNING TG (2008) β-N-methylamino-lalanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicol. Environ. Saf. 71 309-313.
9. FAASSEN EJ, GILLISSEN F, ZWEERS HAJ and LÜRLING M (2009) Detection of the neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (α-.γ-diaminobutyric acid) by LC-MS/MS in Dutch urban waters with cyanobacterial blooms. Amytrophic Lateral Sclerosis 2009 (2) 79-84.
10. KRÜGER T, MÖNCH B, OPPENHÄUSER S and LUCKAS B (2010) LC-MS/MS determination of the isomeric neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius. Toxicon 55 547-557.
11. KUSHNIR MM and BERGQUIST J (2009) Beta-methylamino-Lalanine analysis by liquid chromatography tandem mass spectrometry with iTRAQ as the derivative. Eur. J. Mass. Spectrom. 15 (3) 439-43.
12. LOBNER D, PIANA PM, SALOUS AK and PEOPLES RW (2007) β-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol. Dis. 25 360-366.
13. METCALF JS, BANACK SA, LINDSAY J, MORRISON LF, COX PA and CODD GA (2008) Co-occurrence of β-N-methylamino-Lalanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Environ. Microbiol. 10 702-708.
14. MONSON CS, BANACK SA and COX PA (2003) Conservation implications of Chamorro consumption of flying foxes as a possible cause of ALS-PDC in Guam. Conserv. Biol. 17 678-686.
15. MONTINE TJ, LI K, PERL DP and GALASKO D (2005) Lack of ß-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurol. 65 768-776.
16. MURCH SJ, COX PA, BANACK SA, STEELE JC and SACKS OW (2004a) Occurrence of β-N-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 110 (4) 267-269.
17. MURCH SJ, COX PA and BANACK SA (2004b) A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. PNAS 101 12228-12231.
18. PABLO J, BANACK SA, COX PA, JOHNSON TE, PAPAPETROPOULAS S, BRADLEY W, BUCK A and MASH DC (2009) Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol. Scand. 120 216-225.
19. RAO SD, BANACK SA, COX PA and WEISS JH (2006) BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 201 244-252.
20. ROSÉN J and HELLENÄS K-E (2008) Determination of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry). Analyst 133 1785-1789.
21. RIPPKA R (1988) Isolation and purification of cyanobacteria. Methods Enzymol. 167 3-28.
22. SNYDER LR, HOGGARD JC, MONTINE JJ and SYNOVEC RE (2010) Development and application of a comprehensive twodimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-L-alanine in human tissue. J. Chromatogr. 1217 4639-4647.
23. SPÁČIL Z, ERIKSSON J, JONASSON S, RASMUSSEN U, ILAG LL and BERGMAN B (2010) Analytical protocol for identification of BMAA and DAB in biological samples. Analyst 135 127-132.
24. VEGA A and BELL EA (1967) α-Amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochem. 6 (5) 759-762.